Randomized phase III study of TS-1 [S-1] alone versus TS-1 plus lentinan(LNT) in advanced or recurrent gastric cancer (ACG)

Trial Profile

Randomized phase III study of TS-1 [S-1] alone versus TS-1 plus lentinan(LNT) in advanced or recurrent gastric cancer (ACG)

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Aug 2016

At a glance

  • Drugs Lentinan (Primary) ; Gimeracil/oteracil/tegafur
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jan 2013 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 22 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top